In particular, NEFL has been reported to be a biomarker of Alzheimer disease,35,36 where CD33 may drive impaired phagocytic capacity of microglia and pose a risk for Alzheimer's disease.32 Here, NEFL is linked to early-onset autosomal dominant Alzheimer disease.